Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Likvor is a Swedish medical technology company specializing in the diagnosis and monitoring of Normal Pressure Hydrocephalus (NPH). The company's flagship product, the Likvor CELDA System, is a specialized medical device designed to accurately measure cerebrospinal fluid (CSF) dynamics, including pressure and flow. By providing clinicians with detailed data on CSF resistance and compensatory mechanisms, Likvor enables more precise identification of patients who would benefit from shunt surgery. The system is used in clinical settings to differentiate NPH from other forms of dementia, improving patient outcomes through early and accurate intervention. Based on research from Umeå University, Likvor continues to advance the field of CSF dynamics through its automated diagnostic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Likvor.